Brief: Molecure Gets Proof Of Concept For mRNA Platform
12/12/2023 14:07
Dec 12 (Reuters) - Molecure SA MOCP.WA :
* GETS PROOF OF CONCEPT IN DISCOVERY PROGRAM SMALL MOLECULES
THAT
TARGET MRNA
* COMPANY ASSESSES THAT OBTAINING PROOF OF CONCEPT IN MRNA
PLATFORM MAY BE MOMENT TO OPEN A POTENTIAL TRANSACTION WINDOW
FOR COMPANY'S MRNA PLATFORM
Source text for Eikon: ID:nEM2vC7sQa
Further company coverage: MOCP.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; 48 58 769 66 00;))
Recent news on Molecure SA
See all newsBrief: Molecure Q1 Net Loss 4.1 Mln Zlotys
Brief: Molecure Says Its In-Consortium Project Selected For Funding By Medical Research Agency
Brief: Molecure To Sell 4.12 Mln Series K Shares and 2.0 Mln Existing Shares At 5 Zlotys/Shr
Brief: Molecure Starts ABB For Up to 4.12 Mln New Series K Shares And Up To 2.0 Mln Existing Shares
Brief: Molecure Signs Conditional Investment Agreement With MS Galleon And Szumowski Investments